Oxford Asset Management’s Theravance Biopharma TBPH Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $159K | Buy |
+14,429
| New | +$159K | 0.06% | 425 |
|
2020
Q1 | – | Sell |
-13,961
| Closed | -$361K | – | 1191 |
|
2019
Q4 | $361K | Sell |
13,961
-1,148
| -8% | -$29.7K | 0.01% | 1372 |
|
2019
Q3 | $294K | Buy |
+15,109
| New | +$294K | 0.01% | 1463 |
|
2015
Q1 | – | Sell |
-172,016
| Closed | -$2.62M | – | 734 |
|
2014
Q4 | $2.62M | Sell |
172,016
-152,321
| -47% | -$2.32M | 0.06% | 325 |
|
2014
Q3 | $7.59M | Buy |
324,337
+77,025
| +31% | +$1.8M | 0.17% | 118 |
|
2014
Q2 | $8.46M | Buy |
+247,312
| New | +$8.46M | 0.27% | 98 |
|